- Open Access
Dendritic retraction, but not atrophy, is consistent in amyotrophic lateral sclerosis-comparison between Onuf’s neurons and other sacral motor neurons-
© Takeda et al.; licensee BioMed Central Ltd. 2014
- Received: 11 December 2013
- Accepted: 16 January 2014
- Published: 27 January 2014
Fundamental cytological changes of amyotrophic lateral sclerosis (ALS) were looked for by comparing relatively preserved Onuf’s nucleus (ON) and severely affected neighboring motor neuron groups (dorsolateral alpha motoneurons (DL) and other anterior horn neurons (OAH)). The second sacral segments from 11 ALS patients and 5 controls were initially quadruple-labeled for phosphorylated and non-phosphorylated TAR DNA-binding protein of 43 kDa (TDP43), and p62 with DAPI to identify TDP43-related changes. After digital recording of these fluorescence data encompassing the entire specimen at a high resolution, the same sections were stained with Klüver-Barrera method to obtain their exact bright-field counterparts. This novel approach facilitated exact identification of ON. Furthermore, this cell to cell comparison enabled to correlate quantitative indices of the neuronal cell bodies: perimeter, area and circularity index (CI) i.e. the ratio of (perimeter/2π) divided by the square root of (area/π), which decreases with dendritic retraction, overall number of neurons and inclusions.
In addition to known preservation of ON neuron number relative to DL and OAH, size reduction of ON neurons was not significant even in the advanced stage. Significant size reduction in DL was counteracted in the presence of TDP43-positive inclusions. Early increase of neuronal size in OAH was further enhanced by the presence of TDP43-positive inclusions. Even with these heterogeneous cytopathological changes, a decrease in CI was consistent in all groups at an early phase and was correlated with neuronal loss.
Among variable cytological changes of ALS, a decrease in CI is a consistent early feature shared between non-atrophic ON neurons and other anterior horn neurons with either decreased (DL) or even increased (OAH) size and profounder neuronal loss. This decrease in CI, representative of dendritic retraction, is fundamental to ALS pathogenesis, not necessarily linked to cell size and pathological inclusions.
- Amyotrophic lateral sclerosis
- Onuf's nucleus
- Anterior horn
Relative preservation of Onuf’s nucleus (ON) at the sacral level of the spinal cord in amyotrophic lateral sclerosis (ALS) explains the sparing of the sphincter muscles, which is in sharp contrast with severe involvement of other upper and lower motor neurons . Even though, the ON is not free from pathological changes: it has indeed been reported that neuronal numbers decrease, that neuronal atrophy with central chromatolysis is common [2, 3], and that skein-like/rounded inclusions [2, 4, 5] or Bunina bodies [2, 6] appear in the ON in ALS patients. However, only a few reports quantified neuronal loss, morphologic changes (shrinkage of cytoplasm and dendrites) and pathological inclusions. Moreover, mutual relationship between these quantified indices has never been reported in ALS. In the present study, we used a quadruple fluorescence method to correlate TAR-DNA binding protein of 43 kDa (TDP43) with or without phosphorylation and p62 epitopes and dislocation of nuclear TDP43 in individual neurons. Digital recording of the entire section by a virtual slide system at a high resolution enabled to capture all the pathological alterations of ALS, which are highly variable from a neuron to another. Subsequent Klüver-Barrera (KB) staining of the same section followed by similar digitalization enabled to compare the neuronal morphology (KB-stained image) and the epitope presentation (multifluorolabeled image), quantifiable on each neuron throughout the section. This novel strategy, correlative morphometry, appeared very useful to evaluate how quantified indices were correlated with each other on a cell to cell basis. Through comprehensive quantification of those morphological indices in the second sacral segment from two groups of patients with ALS deceased early or late after the onset, it was possible to compare the differences of morphology and neuronal counts in each; 1) region (ON, dorsolateral alpha-motoneuron group and the other areas), 2) phase (early and advanced), and to assess possible influences of TDP43-positive inclusions to these changes. This cell to cell comparison at different time points and in different neuronal groups clarifies what are consistent and fundamental among the morphological changes found in human ALS samples as the first step for understanding the selective neuronal vulnerability of ALS.
A sample from the second sacral segment was obtained from eleven patients with sporadic ALS (six early and five advanced cases, each with Bunina bodies) and five control patients without any neurological complications. This study on human samples was performed following The Code of Ethics of the World Medical Association (Declaration of Helsinki) as approved by Institutional Review Board of Tokyo Metropolitan Institute of Medical Science (No 13-22). ALS was defined as early when the patient had died within 1 year after the onset. ALS was considered as advanced when the patient had survived more than 5 years. Patients with any degree of dementia or history of artificial ventilation were excluded. All the post mortem specimens were stored at the Department of Neuropathology of Aichi Medical University (Additional file 1: Table S1). These samples were routinely fixed in formalin and embedded in paraffin to obtain 5 μm-thick sections. After treatment with Sudan-black to reduce autofluorescence of lipofuscin , quadruple-fluorolabeling was performed. After incubation with a mixture of three primary antibodies against non-phosphorylated TDP43 (TDP43, polyclonal, rabbit, 1:3,000, Protein Tech, Chicago, Illinois) [8, 9], phosphorylated TDP43 (pTDP43, monoclonal, TIP-PTD-M01, mouse, 1:3,000; Cosmo Bio, Tokyo, Japan)  and p62 (polyclonal, guinea pig, 1:3,000, Progen, Heidelberg, Germany) , the sections were reacted with fluorolabeled secondary antibodies. The epitope for p62 was visualized with biotinylated anti-guinea pig IgG (1:200, Vector, Burlingame, CA)/streptavidin-Alexa Fluor 647R (1:200, Molecular Probes, Eugene, OR) . The epitope for TDP43 was visualized with an anti-rabbit IgG conjugated with Alexa Fluor 546R (1:200, Molecular Probes, Eugene, OR) and that for pTDP43 with an anti-mouse IgG conjugated with Alexa Fluor 488R (1:200, Molecular Probes, Eugene, OR). The nuclei were visualized with DAPI (4′, 6-diamino-2-phenylindole, dihydrochloride, 1:200, Molecular Probes, Eugene, Oregon) for 15 minutes. Fluorescent scanning microscopy (A model equivalent to Pannoramic scan, 3D-Histech, Hungary) enabled to obtain a high-resolution (0.2325 μm/pixel) image of each fluorescence signal tiled to encompass the entire specimen up to 25 × 75 mm (1.08 × 105 × 3.24 × 105 pixels), recorded as digital data. After digital recording of the fluorescent signals, coverslips were removed and the same slides were subjected to KB stain to yield the bright-field counterpart of the fluorescence images, similarly scanned by the same equipment. Once the quadruple fluorescence images had been captured as digital data, identification of all fluoropositive lesions throughout the anterior horn (AH) was possible on the corresponding software, which displays whatever region of interest at whatever magnification (Pannoramic viewer, 3D-Histech, Hungary). Its direct comparison with the KB counterpart (Pannoramic viewer) ensured the precise localization of each fluorescent lesion throughout the AH.
Statistical analyses made use of one-way ANOVA and post hoc Scheffe’s multicomparison test (Ekuseru-Toukei 2012, Social Survey Research Information Co., Ltd. Tokyo, Japan) to look for possible differences in neuronal counts and cytological changes (area, perimeter, CI) between stages (control-early-advanced), locations (DL-OAH-ON) and cytopathology (control-with inclusion-without inclusion). The translocation of TDP43 from the nucleus was also analyzed for possible differences between neurons with granular/dot-like deposits and skein-like/rounded inclusions, and between neurons at the early and the advanced phase. Correlation between neuronal count and area or CI was assessed by Spearman’s rank correlation coefficient. A p value <0.05 was regarded as statistically significant.
Relative preservation of ON neuron even at the advanced phase
Preserved perimeter and area of surviving ON neurons even at the advanced phase
The large and medium neurons of DL decreased in number with progression of illness (Figure 4d, Additional file 2: Table S2). Mean perimeter (Figure 4g) and area (Figure 4j) also decreased in early and advanced phases (Additional file 3: Table S3). In OAH, small neurons, a majority in this group, was markedly decreased already in the early phase, which is at variance with the sparing of small neurons in DL (Figure 4e). Mean area of surviving neurons in OAH at the early phase was larger than that of control (p < 0.001) and returned to the control range in the advanced phase (p < 0.001) (Figure 4k, F = 21.2, df = 4 for a comparison between the 5 groups -control, early inclusion negative, early inclusion positive, advanced inclusion negative, and advanced inclusion positive-, Additional file 3: Table S3). This transient increase in the mean area of OAH neurons at the early phase was not accompanied by the parallel increase in their perimeter (Figure 4h), while the mean perimeter of OAH neurons at the advanced phase was not decreased relative to controls (Figure 4h). The perimeter (Figure 4i) and area (Figure 4l) of ON neurons were stable throughout the early and advanced phase without significant differences relative to controls. The number of large neurons in the ON did not change although those of small neurons decreased (Figure 4f, Additional file 2: Table S2).
Retraction of dendrites at the early phase in ON as well as in DL and OAH
The CI decreases in parallel with retraction of neuronal appendages (dendrites) or with rounding of neurons. It decreased at the early phase not only in DL (Figure 4m, F = 6.7, df = 4, p < 0.001, Additional file 3: Table S3), where the mean area of neurons also decreased (Figure 4j), but also in OAH (Figure 4n, F = 21.2, df = 4, p < 0.001), where the mean area of neurons increased (Figure 4k). The CI also decreased at the early phase in ON (Figure 4o, F = 5.0, df = 4, p = 0.003), where the mean area remained stable (Figure 4l). Its subsequent change at the advanced phase was limited to OAH neurons, where it was elevated (Figure 4n, F = 21.2, df = 4, p = 0.008).
Inclusion-associated increase in neuron size in DL and OAH was absent in ON
Inclusion formation in the ON was observed in both early and advanced phase as well as in the DL and OAH. In DL and OAH at the early phase, the perimeters and areas of neurons with inclusions were larger than those without inclusions (DL perimeter: Figure 4g, F = 31.6, df = 4, p = 0.001; DL area: Figure 4j, F = 33.2, df = 4, p = 0.002; OAH perimeter: Figure 4h, F = 15.1, df = 4, p < 0.001; OAH area: Figure 4k, F = 26.2, df = 4, p < 0.001). In the ON, however, these were not significantly different between ALS patients and controls regardless of the presence of inclusions both at the early and advanced phases. The presence of inclusions had no influence on the CI, in all regions (Figure 4m-o).
Retraction of dendrites as a consistent trend along neuronal loss
In the present study, comparison of different neuronal groups in the sacral segment of ALS patients showed that the intensity and the progression of the neuronal loss were both attenuated in ON (-47.2%, Figure 4c) relative to DL (-78.0%, Figure 4a) and OAH (-71.3%, Figure 4b). Although this relative preservation of ON neuron is compatible with previous reports [1, 18], our novel strategy of correlative morphometry further characterized the specificity of ON neurons in the course of the disease 1) neuronal perimeter and area of surviving ON neurons remained stable even at the advanced phase, 2) their CI decreased at the early phase -a change that we interpret as evidence of dendritic retraction-, and 3) these parameters were not influenced by the presence of inclusions (Figure 4). This is in contrast with the DL and OAH where the presence of an inclusion was associated with an increase in the area. The decrease in CI was associated with a decrease in cell body area in DL. Unexpectedly, surviving OAH neurons exhibited an increase in area, paradoxically correlated with a decrease in CI at the early phase.
Morphometric studies of the ON neurons are still limited probably due to difficulties in identifying a sufficient number of them. Reports, however, mention that normal neurons decrease in number when the number of abnormal neurons increases ; the mean area of neuron cell body is normal  or decreases . The mean area of neurons is larger when they contain inclusion than when they do not ; the shape (especially of dendrites) does not change . Inclusions (Bunina bodies, skein-like inclusions and round inclusions) are present in ON neurons [2, 5, 6]. Most of the previous studies dealt with a single morphological parameter studied in one single sacral section. In the present study, correlations between neuronal count, perimeter and area could be investigated. The correlation between the perimeter, area, and CI of neurons with or without inclusion could be analyzed on a cell to cell basis. Comparison between the parameters collected in ON, DL and OAH allowed to further contrast morphological features of ON.
Attenuated loss and dendritic retraction without size change characterize ON neurons
This study showed that the number of neurons in DL (large motor neurons group) and OAH (the other anterior horn region predominantly containing small neurons) significantly decreased up to 70-80% already at the early phase of the disease in OAH and at the advanced phase in DL. By contrast, those of the ON decreased at the most by 40-50% [20, 21]. Both neuronal loss (neuron counts) and atrophy (area in the present study) characterize neurodegeneration and one could assume that they progress in parallel [20, 22, 23]. This parallelism was clear-cut in DL (Figure 4), while the area of surviving neurons remained unchanged in ON and even increased in OAH. Measurement of neuronal area in different brain regions (anterior horn of the spinal cord, motor nuclei of brainstem cranial nerves and 5th layer of the precentral gyrus) have demonstrated regional heterogeneity and failed to identify a consistent morphological feature shared by all ALS neurons . Even in a single sacral segment (as studied here), heterogeneity between neuronal groups was evident. However, we identified a decrease in CI, probably related to dendrite retraction, as a consistent early feature even in neuronal groups in which neuronal loss and atrophy were heterogeneous (Figure 4) [24, 25]. Because further decrease in CI at the advanced phase was not significant even in DL with progressive loss of neurons, dendritic retraction may be a process that reaches a plateau (maximal level) at the early phase. Otherwise, further dendritic retraction may lead to neuronal loss, which is not accessible through morphometric approach of surviving neurons. (Figure 4j-o) . Decrease in CI may occur if elongated neuronal cytoplasm becomes closer to the exact circle (rounding). Although it remains to be clarified whether such rounding is also related to neurite retraction or not, similar approach was already successful for evaluating neurite morphology in human samples . At present, under the limitation of method and human samples, it is reasonable to assume that the CI is one of the best possible and practically feasible indices for neuronal appendages of small number of neurons such as ON.
The mean area of ON neurons’ cell body did not increase in the presence of inclusions
Although inclusions are hallmarks of many neurodegenerative diseases, it still remains to be settled how they influence the cell survival and morphology [26–28]. With our novel strategy of correlative morphometry, we could show that the inclusion-associated increase in neuronal area was a feature shared by DL and OAH groups (Figure 4). In our previous study, the presence of nuclear inclusion in pontine neurons of Machado-Joseph disease was associated with an increase in nuclear area relative to atrophic neurons without inclusion, suggesting anti-atrophic influence of nuclear inclusions [17, 29, 30], as demonstrated in DL (Figure 4) or a previous report on ALS . In early OAH, however, the mean area of neurons without inclusions was larger than in controls. Because an additional increase was associated with inclusions, it is probable that inclusions of OAH neurons are related to a kind of hypertrophic (anti-atrophic) process, as we reported it with intranuclear inclusion body disease . Similar increase in area in the OAH neurons without inclusions may represent an intrinsic feature of OAH neurons, not necessarily linked to the presence of inclusion. It is also possible that small inclusions, not detectable on the two-dimensional plane of the section, are however present in another plane and still exert such a hypertrophic effect. Such a possibility could only be confirmed by a three-dimensional reconstruction as we reported on glial cytoplasmic inclusions of multiple system atrophy . On the other hand, in ON, the cell body area of neurons with or without inclusions did not differ significantly.
By contrast, the presence of inclusion had no influence on CI in DL, OAH and ON. A previous report suggested that inclusions were preferentially formed in large neurons , our present study demonstrated, however, that these were also observed in small and medium neurons (Figure 6, Additional file 5: Table S5).
It remains to be clarified how abnormal aggregation of TDP43 influences degeneration of motor neurons in ALS patients. A recent experiment on developing drosophila reveals that dendritic branching of sensory neurons increases when normal drosophila TDP43 is overexpressed. Loss of TDP43 in a genetic null mutant or through si RNA, as well as its mutation, decreases dendritic branching . C-terminal TDP43 fragments also impairs dendritic growth whereas normal full-length TDP43 rescues the phenotype in neuronal cultures . TDP43 with missense mutations induces dendritic elongation rather than contraction in cultured cell. Suppression of endogenous TDP43 by si RNA induces similar dendritic abnormalities and cell death . Although it remains to be clarified which of the molecular alterations of TDP43 -overexpression, pathological mutation or truncation-, is responsible for the pathological changes observed in ALS patients, it is probable that similar dendritic retraction as supported in the present study in human autopsy samples is fundamental to ALS pathogenesis.
Our multiple immunofluorolabeling demonstrated frequent colocalization of p62 and pTDP43 in rounded inclusions in the cytoplasm, probably representative of advanced stage or inclusion formation (Figure 3b, thick arrow). Granular cytoplasmic deposits lacking pTDP43 and p62 immunoreactivity (Figure 3d,f,g, thin arrow) may represent an earlier stage of inclusion formation. However, there were no statistical differences of perimeter, area and CI between the groups (Figure 7, Additional file 6: Table S6). This putative evolution from granular cytoplasmic inclusions to rounded inclusion is compatible with the more frequent translocation of TDP43 from nucleus to cytoplasm with rounded inclusions than with granular inclusions. Translocation of TDP43 from nucleus was similarly observed in surviving neurons at the early and the advanced stages without significant difference (57.7% vs. 37.5%: p = 0.317, Additional file 4: Table S4). Even though each of these findings has already been partly published [35, 36], our multiple immunofluorolabeling allowed to study the correlations between these changes at a cellular level. Recent reports revealed that the mislocalization of TDP43 (loss of nuclear TDP43 and cytoplasmic aggregation of TDP43) may lead to a suppression of mRNA transcripts, abnormal cytoplasmic-nuclear RNA transport, or local translation of mRNA. These disruptions of RNA function possibly induce cellular abnormalities including dendritic retraction possibly leading to motor neuron degeneration as suggested by the present study involving human brain tissue [32, 33, 37, 38].
Retraction of dendrites as a consistent feature of ALS neurons
A decrease in the mean cell body area (atrophy) is generally believed to be the prelude of neuronal loss [20, 22, 23]; it was indeed the case in DL (Figure 8a,d). Quite unexpectedly, however, we could not demonstrate such a correlation in ON (Figure 8c,f). The correlation was significant but reversed in OAH (Figure 8b,e). Similarly, a decrease in CI may naturally precede neuronal loss. This was indeed the case for all the neuronal groups (Figures 8g-l) with significant correlation in DL (p = 0.007, Figure 8g) and OAH (p = 0.013, Figure 8h) groups when the neurons without inclusions were considered. The lack of a significant correlation in ON (p = 0.072) may be explained by the rostrocaudal extension of most of the dendrites of ON neurons . Those dendrites have probably no or but a small influence on the CI measured in a transverse plane, as in the present study. Moreover, attenuated neuronal loss and maintained neuronal cell body area in ON might blur this correlation, even though a decrease in CI is significant at the early stage (Figure 4o). It is also possible that morphological changes of ALS neurons are so variable from a neuron to another or from a patient to another to escape or distort expected correlation as seen in some cases with severe neuronal loss but relatively preserved neuronal area (Figures 8e, f) and dendritic arborization (Figures 8k, l). Anyway, the decrease in CI appears to be the most consistent, and therefore fundamental change in ALS than alteration of the area of the neuronal cell body.
A section from the sacral segment of ALS patients and controls was studied. After triple (p62, TDP43, pTDP43) immunofluorescence and DAPI staining, followed by KB technique, the area, perimeter and CI of each neuron belonging to different neuronal groups (DL, OAH and ON) were measured. The relation between these variables and TDP43 immunoreactivity was investigated. Attenuated neuronal loss and preservation of the neuronal size were characteristic of ON. Presence of TDP43-positive inclusions was associated with an increase in neuron size in DL and OAH, while this influence was not significant in ON. Although neuronal loss, size and influence of TDP43-positive inclusions were variable according to neuronal groups, drop of CI, related to dendritic retraction, was a consistent feature shared by all studied neuronal groups (DL, OAH and ON). The present study demonstrated that dendritic retraction may be a fundamental morphological change underlying ALS pathogenesis. Three-dimensional reconstruction could even increase the observed prevalence of these changes in ALS. Neuronal loss finally appears a late event. Inclusion formation and neurite abnormalities occur much earlier. They, rather than neuronal death, possibly provide a better basis to develop new biomarkers and therapeutic targets.
Written informed consent for research use of autopsy materials was obtained from the patient’s guardian/parent/next of kin.
We are grateful to Professor Dr. Makoto Iwata (Tokyo Women’s Medical University) for his encouragement. This study is supported by Grant for Comprehensive Research on Disability Health and Welfare from the Japanese Society for Rehabilitation of Persons with Disabilities (Ministry of Health Labor and Welfare), Grants-in-Aid for Scientific Research (JSPS KAKENHI 25430057) from the Ministry of Education, Culture, Sports, Science and Technology, Grant from Japan Foundation for Neuroscience and Mental Health, the Mitsui Life Social Welfare Foundation, and the Tokyo Metropolitan Institute of Medical Science project ‘Mechanism for Early Diagnosis and Prevention of Parkinson’s disease.
- Mannen T, Iwata M, Toyokura Y, Nagashima K: Preservation of a certain motoneurone group of the sacral cord in amyotrophic lateral sclerosis: its clinical significance. J Neurol Neurosurg Psychiatry 1977, 40: 464–469. 10.1136/jnnp.40.5.464View ArticlePubMedPubMed CentralGoogle Scholar
- Okamato K, Hirai S, Ishiguro K, Kawarabayashi T, Takatama M: Light and electron microscopic and immunohistochemical observation of Onuf’s nucleus of amyotrophic lateral sclerosis. Acta Neuropathol 1991, 81: 610–614. 10.1007/BF00296370View ArticleGoogle Scholar
- Kihira T, Yoshida S, Yoshimasu F, Wakayama I, Yase Y: Involvement of Onuf’s nucleus in amyotrophic lateral sclerosis. J Neurol Sci 1997, 147: 81–88. 10.1016/S0022-510X(96)05313-0View ArticlePubMedGoogle Scholar
- Kihira T, Mizusawa H, Tada J, Namikawa T, Yoshida S, Yase Y: Lewy body-like inclusions in Onuf’s nucleus from two cases of sporadic amyotrophic lateral sclerosis. J Neurol Sci 1993, 115: 51–57. 10.1016/0022-510X(93)90066-8View ArticlePubMedGoogle Scholar
- Bergmann M, Volpel M, Kuchelmeister K: Onuf’s nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci 1995, 129: 141–146. 10.1016/0022-510X(94)00263-NView ArticlePubMedGoogle Scholar
- Kihira T, Yoshida S, Uebayashi Y, Yase Y, Yoshimasu F: Involvement of Onuf’s nucleus in ALS. Demonstration of intraneuronal conglomerate inclusions and Bunina bodies. J Neurol Sci 1991, 104: 119–128. 10.1016/0022-510X(91)90300-VView ArticlePubMedGoogle Scholar
- Schnell SA, Staines WA, Wessendorf MW: Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999, 47: 719–730. 10.1177/002215549904700601View ArticlePubMedGoogle Scholar
- Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006, 351: 602–611. 10.1016/j.bbrc.2006.10.093View ArticlePubMedGoogle Scholar
- Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314: 130–133. 10.1126/science.1134108View ArticlePubMedGoogle Scholar
- Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle FE, Akiyama H, Hisanaga S, Hasegawa M: Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 2008, 582: 2899–2904. 10.1016/j.febslet.2008.07.027View ArticlePubMedGoogle Scholar
- Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H: p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002, 160: 255–263. 10.1016/S0002-9440(10)64369-6View ArticlePubMedPubMed CentralGoogle Scholar
- Wooten MW, Seibenhener ML, Mamidipudi V, Diaz-Meco MT, Barker PA, Moscat J: The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kB activation by nerve growth factor. J Biol Chem 2001, 276: 7709–7712. 10.1074/jbc.C000869200View ArticlePubMedGoogle Scholar
- Rexed B: The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol 1952, 96: 415–495. 10.1002/cne.900960303View ArticleGoogle Scholar
- Schoenen J, Faull R: Spinal cord: Cyto- and Chemoarchitecture. In The Human Nervous System. 2nd edition. Edited by: Paxinos G, Mai J. San Diego: Academic Press; 2004:190–232.View ArticleGoogle Scholar
- Terao S, Sobue G, Hashizume Y, Mitsuma T, Takahashi A: Disease-specific patterns of neuronal loss in the spinal ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked recessive bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone. J Neurol 1994, 241: 196–203. 10.1007/BF00863768View ArticlePubMedGoogle Scholar
- Pullen AH, Tucker D, Martin JE: Morphological and morphometric characterisation of Onuf’s nucleus in the spinal cord in man. J Anat 1997, 191(Pt 2):201–213.View ArticlePubMedPubMed CentralGoogle Scholar
- Uchihara T, Iwabuchi K, Funata N, Yagishita S: Attenuated nuclear shrinkage in neurons with nuclear aggregates–a morphometric study on pontine neurons of Machado-Joseph disease brains. Exp Neurol 2002, 178: 124–128. 10.1006/exnr.2002.8028View ArticlePubMedGoogle Scholar
- Schrøder HD, Reske-Nielsen E: Preservation of the nucleus X-pelvic floor motosystem in amyotrophic lateral sclerosis. Clin Neuropathol 1984, 3: 210–216.PubMedGoogle Scholar
- Kiernan JA, Hudson AJ: Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis. Brain 1993, 116(Pt 1):203–215.View ArticlePubMedGoogle Scholar
- Stephens B, Guiloff RJ, Navarrete R, Newman P, Nikhar N, Lewis P: Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. J Neurol Sci 2006, 244: 41–58. 10.1016/j.jns.2005.12.003View ArticlePubMedGoogle Scholar
- Iwata M: Onuf-Mannen’s nucleus. Jpn Med Assoc J 2011, 54: 45–50.Google Scholar
- Murakami T: Motor neuron disease: quantitative morphological and microdensitophotometric studies of neurons of anterior horn and ventral root of cervical spinal cord with special reference to the pathogenesis. J Neurol Sci 1990, 99: 101–115. 10.1016/0022-510X(90)90204-ZView ArticlePubMedGoogle Scholar
- Kiernan JA, Hudson AJ: Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 1991, 114(Pt 2):843–853.View ArticlePubMedGoogle Scholar
- Kato T, Hirano A: A Golgi study of the large anterior horn cells of the lumbar cords in normal spinal cords and in amyotrophic lateral sclerosis. Acta Neuropathol 1987, 75: 34–40. 10.1007/BF00686790View ArticlePubMedGoogle Scholar
- Nakano I, Hirano A: Atrophic cell processes of large motor neurons in the anterior horn in amyotrophic lateral sclerosis: observation with silver impregnation method. J Neuropathol Exp Neurol 1987, 46: 40–49. 10.1097/00005072-198701000-00004View ArticlePubMedGoogle Scholar
- Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH: The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 2012, 124: 339–352. 10.1007/s00401-012-1022-4View ArticlePubMedGoogle Scholar
- Ross CA, Poirier MA: Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 2005, 6: 891–898. 10.1038/nrm1742View ArticlePubMedGoogle Scholar
- Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ: Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013, 125: 777–794. 10.1007/s00401-013-1125-6View ArticlePubMedPubMed CentralGoogle Scholar
- Uchihara T, Tanaka J, Funata N, Arai K, Hattori T: Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol 2003, 105: 103–108.PubMedGoogle Scholar
- Uyama N, Uchihara T, Mochizuki Y, Nakamura A, Takahashi R, Mizutani T: Selective nuclear shrinkage of oligodendrocytes lacking glial cytoplasmic inclusions in multiple system atrophy: a 3-dimensional volumetric study. J Neuropathol Exp Neurol 2009, 68: 1084–1091. 10.1097/NEN.0b013e3181b67678View ArticlePubMedGoogle Scholar
- Stephens B, Navarrete R, Guiloff RJ: Ubiquitin immunoreactivity in presumed spinal interneurones in motor neurone disease. Neuropathol Appl Neurobiol 2001, 27: 352–361. 10.1046/j.1365-2990.2001.00354.xView ArticlePubMedGoogle Scholar
- Lu Y, Ferris J, Gao FB: Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. Mol Brain 2009, 2: 30. 10.1186/1756-6606-2-30View ArticlePubMedPubMed CentralGoogle Scholar
- Yang C, Tan W, Whittle C, Qiu L, Cao L, Akbarian S, Xu Z: The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS One 2010, 5: e15878. 10.1371/journal.pone.0015878View ArticlePubMedPubMed CentralGoogle Scholar
- Han JH, Yu TH, Ryu HH, Jun MH, Ban BK, Jang DJ, Lee JA: ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons. Exp Cell Res 2013, 319: 1998–2005. 10.1016/j.yexcr.2013.05.025View ArticlePubMedGoogle Scholar
- Mori F, Tanji K, Zhang H, Nishihira Y, Tan C, Takahashi H, Wakabayashi K: Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 2008, 116: 193–203. 10.1007/s00401-008-0396-9View ArticlePubMedGoogle Scholar
- Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M, Pellerino A, Buccinna B, Lupino E, Rinaudo MT: TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol 2010, 20: 351–360. 10.1111/j.1750-3639.2009.00284.xView ArticlePubMedGoogle Scholar
- Sumi H, Kato S, Mochimaru Y, Fujimura H, Etoh M, Sakoda S: Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2009, 68: 37–47. 10.1097/NEN.0b013e3181919cb5View ArticlePubMedGoogle Scholar
- Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S: Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 2010, 30: 639–649. 10.1523/JNEUROSCI.4988-09.2010View ArticlePubMedPubMed CentralGoogle Scholar
- Roppolo JR, Nadelhaft I, de Groat WC: The organization of pudendal motoneurons and primary afferent projections in the spinal cord of the rhesus monkey revealed by horseradish peroxidase. J Comp Neurol 1985, 234: 475–488. 10.1002/cne.902340406View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.